The Obesity Action Coalition (OAC) is pleased to share that Biohaven Pharmaceuticals has joined OAC’s Chairman’s Council at the Bronze level! Thank you for committing to support and champion the OAC’s mission.

About Biohaven Pharmaceuticals

Biohaven is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, metabolic disease, and oncology. The company is advancing its innovative portfolio of therapeutics, leveraging its proven drug development experience and multiple proprietary drug development platforms to meet the unmet needs of people living with disease. The unmet needs of patients inspire us to follow scientific innovation wherever it leads and motivate our resolve for overcoming the obstacles that stand in the way of medical progress. At Biohaven, we know Days Matter. For more information, visit

About the OAC Chairman’s Council

The OAC is honored that Biohaven Pharmaceuticals has chosen to support our organization at the Bronze level through the Chairman’s Council as we strive to partner with industry leaders who share our mission of supporting and empowering individuals in their health journeys.

The OAC welcomes ANY individual, organization or company who wishes to join our highest level of OAC Membership and receive maximum benefits. Our Chairman’s Council is an excellent way to give back to the cause and play an integral role in making the world a better place for people with obesity. To learn more about the OAC’s Chairman’s Council, click here.